Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AC4EC22004060237062
Vitamine d3 + k2 grande boite 365 comprimés 4000 UI cure 1 an Origine Angleterre UK
midtail
3P
MEDICAMENTS
Last 4 weeks demand
36
▼ 14.3% vs prev 4w
Offer Stock
27
Σ Stock across 2 live offers (1P + 3P) · 2026-10-02
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-10-02 snapshot
Unit price
MAD 232
avg of last 30 sells · latest 2026-09-28
AC4EC22004060237062
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-09-28 · Total forecast: 230 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Vitamine d3 + k2 grande boite 365 comprimés 4000 UI cure 1 an Origine Angleterre UK · in the midtail cohort · last 4 weeks 36 units, trending down -14.3% · on-hand 28 units
Signals the model saw
- Cohort: midtail (175 days of history, — units sold over 52 weeks)
- Volatility (CV): 0.82 — moderate
- Recent trend: last 4w = 36 units · prev 4w = 42 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 1.2 units |
| Realistic forecast — next 4 weeks | 5.0 units |
| Realistic forecast — next 3 months | 82.3 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 13.7 units |
| Optimistic — next week | 10.9 units |
| Optimistic — next 4 weeks (reorder target) | 50.2 units |
| Optimistic — next 3 months (quarterly PO target) | 230.5 units |
| Legacy μ/wk (reorder pipeline) | 4.2 |
| Revenue exposure — optimistic, 3 months | MAD 53.4K |